Search

Your search keyword '"Catena, Laura"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Catena, Laura" Remove constraint Author: "Catena, Laura"
139 results on '"Catena, Laura"'

Search Results

2. A resource for the world?

3. Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

4. Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study

5. La difusión y revisión del marxismo en América Latina: José María Aricó y el grupo Pasado y Presente

6. Historia del Socialismo Internacional

24. CAPECITABINE IN ELDERLY PATIENTS WITH ADVANCED BREAST CANCER

25. A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

27. Pact of silence: cultural perspectives of disclosure to terminal patient

29. Abstract LB-256: Impact of metformin on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNETs) receiving everolimus and/or somatostatin analogues: A sensitivity analysis of the PRIME-NET (pancreatic multicentric, retrospective, italian metformin) study

30. La recepción de la obra de Isaac Deutscher por los trotskistas norteamericanos: un capítulo en la historia de la Cuarta Internacional

32. Climate Change: Field Reports from Leading Winemakers

33. The socio-economic formation concept in José María Aricó’s work: a comparison with Marxist sources

34. Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update.

35. Phase II study of everolimus in combination with octreotide LAR in first line setting for patients with neuroendocrine tumors (I.T.M.O. study): A 4-year update.

36. Anarquismo y la emancipación de la mujer: El movimiento anarquista en Argentina y Nuestra Tribuna (1922-1925)

37. Updated overall survival and time to progression results in NETs treated with everolimus combination with octreotide LAR as first-line treatment.

38. Everolimus in combination with octreotide LAR as the first-line treatment for advanced neuroendocrine tumors: A phase II trial of the I.T.M.O. (Italian Trials in Medical Oncology) group.

42. Pitfalls in the Diagnosis of Neuroendocrine Tumors: Atypical Clinical and Radiological Findings as Cause of Medical Mistakes

43. The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study

48. Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Catalog

Books, media, physical & digital resources